- Metan G, Çiftçioğlu A, Saba R, Kılıç AU, Özdemir K, Çağ Y, Ünal DK, Aksoy F, Berk H, Mert G, Tunçcan ÖG, Tombak A, Balkan İİ, Çavuş SA, Kandemir B, Mutlu B, İnkaya AÇ, Kaynar L, Atay MH, Dursun FE, Saydam G, Ünsal Y, Sarı SF, Akan H; Study group. Antifungal Prophylaxis and Treatment of Breakthrough Invasive Fungal Diseases in High-Risk Hematology Patients.A Prospective Observational Multicenter Study. Indian J Hematol Blood Transfus 2025 Jan;41(1):75-88. doi: 10.1007/s12288-024-01790-2.
https://pubmed.ncbi.nlm.nih.gov/39917507/
- Kara E, Metan G, Gülmez D, Arikan-Akdagli S. The impact of the COVID-19 on the antifungal consumption and antifungal resistance in Candida species isolated from the blood cultures of critically ill patients in intensive care units. Med Mycol 2025 Jan 25;63(2):myaf002. doi: 10.1093/mmy/myaf002.
https://pubmed.ncbi.nlm.nih.gov/39814570/
- Karadogan E, Sertcelik A, Dizman GT, Uzar H, Hazirolan G, Cakir B, Metan G. A scoring system to predict resistance to ceftolozane/tazobactam in respiratory isolates of Pseudomonas aeruginosa. J Antimicrob Chemother 2025 Mar 3;80(3):788-796. doi: 10.1093/jac/dkae476.
https://pubmed.ncbi.nlm.nih.gov/39811889/
- Dogan CZ, Kara E, Pinar A, Demirkan K, Metan G. Therapeutic drug monitoring in patients treated with vancomycin: a single center, prospective, observational, real-world study. Eur J Clin Microbiol Infect Dis. 2025 Jun 13. doi: 10.1007/s10096-025-05182-w.
https://pubmed.ncbi.nlm.nih.gov/40512250/
- Ocaklı Aİ, Özyar-Kurtçu ŞA, Uzun M, Kaşıkçı-Çavdar M, Telli-Dizman G, Metan G, Akova M, Sarıbaş Z, Şener B. Quantitative Immunoglobulin G and Interferon-Gamma Responses After Different Booster Strategies of CoronaVac and BNT162b2 Vaccines in Türkiye. Infect Dis Clin Microbiol. 2025 Jun 26;7(2):156-165. doi: 10.36519/idcm.2025.546.
https://pubmed.ncbi.nlm.nih.gov/40657012/
- Ballı Turhan FN, Bakır Ekinci P, Kurtaran M, Kara E, Telli Dizman G, Sönmezer MÇ, Hayran M, Demirkan K, Metan G. In reply to the letter to the editor regarding 'battle of polymyxin induced nephrotoxicity: Polymyxin B versus colistin'. Int J Antimicrob Agents. 2025 Jul 16;66(4):107576. doi: 10.1016/j.ijantimicag.2025.107576.
https://pubmed.ncbi.nlm.nih.gov/40675198/
- Yumrukaya L, Hagens A, İnkaya AÇ, Metan G, Postma M, Yeğenoğlu S, Akova M. Do We Need Meropenem Treatment Beyond 7 Days in Febrile Neutropenic Patients: A Cost-Effectiveness Analysis. Antibiotics (Basel). 2025 Jun 27;14(7):653. doi: 10.3390/antibiotics14070653.
https://pubmed.ncbi.nlm.nih.gov/40723956/
- Aslan AT, Kara E, Köksal G, Bilir Y, Saraçoğlu KT, Eser F, Güner R, Alkan S, D'Avino A, Escudero-Sanchez R, Kutluca K, Kaya SY, Saltoğlu N, Loiacono L, Coladonato S, Del Giacomo P, Cascio A, Pallotto C, Francisci D, Öztürk B, Pınar A, Dağ O, Harris PNA, Paterson DL, Akova M. Comparison of piperacillin-tazobactam and vancomycin (TZP-VAN) with piperacillin-tazobactam and teicoplanin (TZP-TEI) for the risk of acute kidney injury (CONCOMITANT): A prospective observational, multinational, multi-centre cohort study. Int J Antimicrob Agents 2025 Mar;65(3):107446. doi: 10.1016/j.ijantimicag.2025.107446.
https://pubmed.ncbi.nlm.nih.gov/39826571/
- Righi E, Yahav D, Nasim A, Akova M, Barac A, Scudeller L, Nagavci B, Armellini M, Zanchi C, Shirin N, Tunali V, Paño-Pardo JR, Rodríguez-Baño J, Jamrozik E; ESCMID OPENING Project Group. Incorporating ethics into infectious disease clinical practice guidelines. Clin Microbiol Infect 2025 Jan 17:S1198-743X(25)00013-8. xdoi: 10.1016/j.cmi.2025.01.008.
https://pubmed.ncbi.nlm.nih.gov/39827993/
- Moreno-Mellado E, Aslan AT, Akova M, León E, Merchante N, Vinuesa D, Moral-Escudero E, Sadyrbaeva-Dolgova S, López-Cárdenas S, Cano-Yuste Á, Rinaldi M, Núñez-Núñez M, Giannella M, Sojo-Dorado J, Antolí-Royo AC, Chacón N, Merino-Bohórquez V, Portillo I, Rodríguez-Baño J, Docobo-Pérez F, Gutiérrez-Gutiérrez B; FOSFOMIC team. Effectiveness and tolerability of intravenous fosfomycin in treating complicated urinary tract infections caused by Escherichia coli: a prospective cohort study from the FOSFOMIC project. Clin Microbiol Infect 2025 Jan 18:S1198-743X(25)00012-6. doi: 10.1016/j.cmi.2025.01.007.
https://pubmed.ncbi.nlm.nih.gov/39832652/
- Baccelli F, Aguilar-Guisado M, Vİdal CG, Mikulska M, Vanbiervliet Y, Blijlevens N, Munoz P, Neofytos D, Cordonnier C, Calandra T, Averbuch D, Akova M. Epidemiology of resistant bacterial infections in patients with hematological malignancies or undergoing hematopoietic cell transplantation in Europe: A systematic review by the European Conference on Infections in Leukemia (ECIL) J Infect, 2025 Aug 12;91(3):106571.
https://pubmed.ncbi.nlm.nih.gov/40812455/
- Uzar H, Karadoğan E, Sertçelik A, Dizman GT, Hazırolan G, Uzun Ö, Çakır B, Metan G. The impact of an institutional sepsis guideline on selecting appropriate empirical treatment in patients with carbapenem-resistant gram-negative bacilli bacteremia. Eur J Clin Microbiol Infect Dis. 2025 Oct 4.
https://pubmed.ncbi.nlm.nih.gov/41045444/
- Aslan AT, Tanriverdi LH, Hernandez AV, Akova U, Kutluca K, Chan S, Coussement J, Manuel AGJ, Origüen J, Sabé N, Harris PNA, Akova M, Paterson DL. Effectiveness and safety of antibiotics in kidney transplant recipients with symptomatic bacteriuria: A systematic review and meta-analysis of randomized controlled trials. Open Forum Infect Dis. 2025 Aug 19;12(9):ofaf502.
https://pubmed.ncbi.nlm.nih.gov/41018707/
- Yahav D, Nasim A, Shirin N, Armellini M, Zanchi C, Tunali V, Mirandola M, Barac A, Scudeller L, Nagavci B, Paño-Pardo JR, Rodríguez-Baño J, Jamrozik E, Akova M, Righi E. Incorporating ethics in clinical guidelines in infectious diseases: a scoping review. JAMA Netw Open. 2025 Jul 1;8(7):e2519826.
https://pubmed.ncbi.nlm.nih.gov/40638119/
- Boşnak C, Akova M. Febrile neutropenia management in high-risk neutropenic patients: a narrative review on antibiotci prophylaxis and empirical treatment. Expert Rev Anti Infect Ther. 2025 Jun;23(6):327-341.
https://pubmed.ncbi.nlm.nih.gov/40163819
- Rodríguez-Baño J, Skov RL, Friedland JS, Del Río C, Akova M, Zinkernagel AS. The challenge to improving and standardizing training in infectious diseases in Europe. Clin Microbiol Infect. 2025 Jun;31(6):888-889.
https://pubmed.ncbi.nlm.nih.gov/40120760/
- Tanriover MD, Azap A, Cakir Edis E, Ozger HS, Pullukcu H, Sonmezer MC, Dursun OU, Merter S, Sayiner A.Respiratory syncytial virüs (RSV) infections in adults: Current trends and recommendations for prevention – a global challenge from a local perspective. Hum Vaccin Immunother. 2025 Dec;21(1):2514357.
https://pubmed.ncbi.nlm.nih.gov/40530658/
- Elbahr U, Erdem H, Ben Yahia W, Baymakova MP, Letaief A, Poposki K, Grgić S, Sanlidag G, Miftode IL, Marino A, Miftode EG, Amer F, Oncu S, Hasanoglu I, Wegdan AA, Eser F, Guner HR, Kaya Kalem A, Cosentino F, Kolovani E, Tahmaz A, Sonmezer MC, Arapovic J, Ceylan MR, Kayaaslan B, Hakamifard A, Önder T, Eser-Karlidag G, Tehrani HA, Addepalli SK, Kumari HP, Kumar MR, Sayana SB, Sipahi OR.Diagnosis and outcomes of fever of unknown origin cases with an erythrocyte sedimentation rtate of 100 mm/h or more: an international ID-IRI (Infectious Diseases – International Research Initiative) observational retrospective cohort study. Medicine (Baltimore). 2025 Jul 18;104(29):e43341.
https://pubmed.ncbi.nlm.nih.gov/40696644/
- Eser F, Kayaaslan B, Şentürk GÇ, Sönmezer MÇ, Baştuğ A, Birengel S, İnkaya AÇ, Kuzi S, Hatipoğlu ÇA, Sarıcaoğlu EM, İskender G, Yenigün EC, Ünal S. Epidemiology of kidney disease in people living with HIV in Turkiye: Comorbidities and drug toxicities are emergin problems. Curr HIV Res. 2025 Aug 25.
https://pubmed.ncbi.nlm.nih.gov/40873219/
- Özdemir A, Demir T, Polat C, Uzun M, Sönmezer MÇ, Ergünay K, Ünal S, İnkaya AÇ, Pınar A. Molecular epidemiological analysis and investigation of antiretroviral drug resistance profile, including capsid inhibitors, among treatment-naive individuals with HIV-1 in Turkiye. HIV Med. 2025 Sep 7.
https://pubmed.ncbi.nlm.nih.gov/40916183/
- Şahiner Z, Güner M, Balli Turhan FN, Ceylan S, Okyar Baş A, Hafizoğlu M, Karaduman D, Atbaş C, Polat Özer Y, Sönmezer MÇ, Balci C, Doğu BB, Cankurtaran M, İnkaya AÇ, Demirkan K, Ünal S, Halil MG.Phase angle is lower in older adults living with HIV compared to geriatric outpatients: A case-control study. J Clin Med. 2025 Aug 22;14(17):5941.
https://pubmed.ncbi.nlm.nih.gov/40943699/
- Aydogan O, Gözün Şaylan E, Mete B, İnkaya AÇ, Güven Ö. Molecular epidemiology of JC polymavirus genotypes in PLWH from Turkey. J Neurovirol. 2025 Jun;31(3):287-294.
https://pubmed.ncbi.nlm.nih.gov/40353955/
- Ozgen-Top O, Karacaer Z, Ozkan EF, Ozger HS, Saltoglu N, Oztoprak-Cuvalci N, Inal AS, Mutlu B, Boztas D, Zengin R, Azap A, Alp-Cavus S, Acar A, Akcalı DT, Akdemir I, Bayramgurler D, Berk-Cam H, Inkaya AÇ, Dasgın D, Deniz S, Erfan G, Guler O, Ilter N, Kurtaran B, Kutlubay Z, Sayin-Kutlu S, Kocagoz AS, Dinleyici EC, Senol E.Evaulation of clinical characteristics, risk factors and prognosis of herpes zoster (shingles) infection in Turkiye. Int J Infect Dis. 2025 Oct 7:108105.
https://pubmed.ncbi.nlm.nih.gov/41067603/